News
ALIPANC Online Seminar – April 13th, 14:00h CET
Speaker: Prof. Andreas Trumpp Affiliation: German Cancer Research Center (DKFZ) & HI-STEM Title: "Profiling and...
Folate- and aCD47-functionalized lipid nanoparticles efficiently deliver mRNA and remodel pancreatic tumor microenvironment.
ALIPANC researchers demonstrate that functionalization of lipid nanoparticles with "don't eat me signal" blocking...
3rd ALIPANC Scientific Meeting on Pancreatic Cancer
The 3rd Scientific Meeting of ALIPANC brings together more than 80 experts to promote translational research in...
Annual Scientific Meeting 2026
March 13, 2026 Hospital Universitario HM Sanchinarro (Madrid). On-site event Scientific Coordination: Jorge Adeva...
CNIO Seminar: Dr. Florencia McAllister – “Cancer as an ecosystem: how microbes shape tumors”.
We are pleased to announce an upcoming seminar of special interest to the pancreatic cancer research community. On...
ALIPANC researchers conducted a study that links venous thromboembolic disease (VTE) with poorer survival in pancreatic cancer patients
The group led by Andrés Muñoz (Gregorio Marañón Hospital, Madrid) has published a subanalysis of the ONCOTHROMB12-01...
Pancreatic Cancer Conference, London 2026 – Cancer Research UK
Registration is now open for the Pancreatic Cancer Conference organised by Cancer Research UK. The event will take...
ALPANC researchers publish study protocol comparing 3D modeling versus conventional CT
3D-PANC study protocol: Is three-dimensional imaging technology superior to computed tomography for assessing the...
New potential therapeutic target for pancreatic cancer identified by ALIPANC researchers
The study by Parejo-Alonso et al. identifies PPAR-δ as a critical transcription factor mediating pancreatic cancer...
ALIPANC researchers develop a new therapeutic combination in preclinical models of pancreatic cancer.
This study conducted by researchers from Vigo presents an innovative sequential therapeutic strategy against...